WallStreetZenWallStreetZen

NASDAQ: WHWK
Whitehawk Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their WHWK stock forecasts and price targets.

Forecast return on equity

Is WHWK forecast to generate an efficient return?

Company
-42.79%
Industry
145.91%
Market
81.63%
WHWK's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is WHWK forecast to generate an efficient return on assets?

Company
-31.94%
Industry
35.93%
WHWK is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

WHWK earnings per share forecast

What is WHWK's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.69
Avg 2 year Forecast
-$1.08
Avg 3 year Forecast
-$1.03

WHWK revenue forecast

What is WHWK's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$100.0M+284.87%
Avg 2 year Forecast
$29.9M+15.08%
Avg 3 year Forecast
$32.2M+23.93%
WHWK's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

WHWK revenue growth forecast

How is WHWK forecast to perform vs Biotechnology companies and vs the US market?

Company
7.41%
Industry
64.11%
Market
10.33%
WHWK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
WHWK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

WHWK vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
WHWK$1.54N/AN/A
XCUR$11.36N/AN/A
AGEN$2.87$5.00+74.22%Hold
MCRB$8.16$80.00+880.39%Buy
ACOG$4.56$20.00+338.60%Buy
View Top Biotech Stocks

Whitehawk Therapeutics Stock Forecast FAQ

What is WHWK's earnings growth forecast for 2025-2027?

(NASDAQ: WHWK) Whitehawk Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.2%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.12%.

Whitehawk Therapeutics's earnings in 2025 is -$63,691,000.On average, 3 Wall Street analysts forecast WHWK's earnings for 2025 to be -$32,281,386, with the lowest WHWK earnings forecast at -$60,820,003, and the highest WHWK earnings forecast at -$1,403,539. On average, 2 Wall Street analysts forecast WHWK's earnings for 2026 to be -$50,527,387, with the lowest WHWK earnings forecast at -$56,141,542, and the highest WHWK earnings forecast at -$44,913,233.

In 2027, WHWK is forecast to generate -$48,188,157 in earnings, with the lowest earnings forecast at -$48,188,157 and the highest earnings forecast at -$48,188,157.

If you're new to stock investing, here's how to buy Whitehawk Therapeutics stock.

What is WHWK's revenue growth forecast for 2025-2027?

(NASDAQ: WHWK) Whitehawk Therapeutics's forecast annual revenue growth rate of 7.41% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.33%.

Whitehawk Therapeutics's revenue in 2025 is $25,983,000.On average, 1 Wall Street analysts forecast WHWK's revenue for 2025 to be $4,678,461,800, with the lowest WHWK revenue forecast at $4,678,461,800, and the highest WHWK revenue forecast at $4,678,461,800. On average, 1 Wall Street analysts forecast WHWK's revenue for 2026 to be $1,398,860,078, with the lowest WHWK revenue forecast at $1,398,860,078, and the highest WHWK revenue forecast at $1,398,860,078.

In 2027, WHWK is forecast to generate $1,506,464,700 in revenue, with the lowest revenue forecast at $1,506,464,700 and the highest revenue forecast at $1,506,464,700.

What is WHWK's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: WHWK) forecast ROA is -31.94%, which is lower than the forecast US Biotechnology industry average of 35.93%.

What is WHWK's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: WHWK) Whitehawk Therapeutics's current Earnings Per Share (EPS) is -$2.36. On average, analysts forecast that WHWK's EPS will be -$0.69 for 2025, with the lowest EPS forecast at -$1.30, and the highest EPS forecast at -$0.03. On average, analysts forecast that WHWK's EPS will be -$1.08 for 2026, with the lowest EPS forecast at -$1.20, and the highest EPS forecast at -$0.96. In 2027, WHWK's EPS is forecast to hit -$1.03 (min: -$1.03, max: -$1.03).

What is WHWK's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: WHWK) forecast ROE is -42.79%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.